Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-surface glycans are complex carbohydrate structures covalently attached to proteins (glycoproteins), lipids (glycolipids), or proteoglycans on the exterior surface of cells. These molecules form a dense and dynamic layer known as the glycocalyx, which plays critical roles in cell-cell communication, signaling, adhesion, migration, immune response modulation, and disease progression. Alterations in cell-surface glycan structures are associated with cancer progression/metastasis, autoimmune diseases, and infectious diseases. Engineering or targeting specific glycans is an emerging therapeutic strategy.
Glycan engineering or targeting
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell-Surface Glycan.